Healios K.K. (HLOSF)
USD 1.35
(0.0%)
USD 1.35
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 450 Million JPY | 1418.5% |
| 2022 | 29.63 Million JPY | -49.95% |
| 2021 | 59.21 Million JPY | -44.67% |
| 2020 | 107.01 Million JPY | 15.29% |
| 2019 | 92.82 Million JPY | -96.33% |
| 2018 | 2.52 Billion JPY | 14.92% |
| 2017 | 2.19 Billion JPY | -7.25% |
| 2016 | 2.37 Billion JPY | 0.0% |
| 2015 | - JPY | 0.0% |
| 2014 | - JPY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 2.04 Billion JPY | 355.33% |
| 2024 Q1 | 2.97 Million JPY | 0.0% |
| 2023 Q1 | 29.38 Million USD | -0.84% |
| 2023 FY | 450 Million JPY | 1418.5% |
| 2023 Q3 | 22 Million USD | -19.03% |
| 2023 Q4 | 3.18 Million USD | -85.5% |
| 2023 Q2 | 27.17 Million USD | -7.53% |
| 2022 Q3 | 47.44 Million JPY | -5.96% |
| 2022 FY | 29.63 Million JPY | -49.95% |
| 2022 Q4 | 29.63 Million JPY | -37.54% |
| 2022 Q1 | 6.83 Billion JPY | 0.25% |
| 2022 Q2 | 50.45 Million JPY | -99.26% |
| 2021 Q1 | 101.07 Million JPY | -99.1% |
| 2021 FY | 59.21 Million JPY | -44.67% |
| 2021 Q4 | 6.81 Billion JPY | 0.26% |
| 2021 Q3 | 6.79 Billion JPY | 6582.2% |
| 2021 Q2 | 101.74 Million JPY | 0.66% |
| 2020 FY | 107.01 Million JPY | 15.29% |
| 2020 Q1 | 10.52 Billion JPY | 3.61% |
| 2020 Q2 | 9.1 Billion JPY | -13.47% |
| 2020 Q3 | 8.19 Billion JPY | -10.05% |
| 2020 Q4 | 11.28 Billion JPY | 37.71% |
| 2019 Q1 | 2.5 Billion JPY | -6.05% |
| 2019 Q4 | 10.15 Billion JPY | -11.67% |
| 2019 Q3 | 11.5 Billion JPY | 360.0% |
| 2019 Q2 | 2.5 Billion JPY | 0.0% |
| 2019 FY | 92.82 Million JPY | -96.33% |
| 2018 FY | 2.52 Billion JPY | 14.92% |
| 2018 Q4 | 2.66 Billion JPY | 69.49% |
| 2018 Q2 | 1.61 Billion JPY | 933.97% |
| 2018 Q3 | 1.57 Billion JPY | -2.67% |
| 2018 Q1 | 156 Million JPY | -92.91% |
| 2017 Q3 | 2.24 Billion JPY | -1.88% |
| 2017 FY | 2.19 Billion JPY | -7.25% |
| 2017 Q1 | 2.32 Billion JPY | -1.81% |
| 2017 Q2 | 2.28 Billion JPY | -1.85% |
| 2017 Q4 | 2.19 Billion JPY | -1.92% |
| 2016 FY | 2.37 Billion JPY | 0.0% |
| 2016 Q4 | 2.37 Billion JPY | -1.78% |
| 2016 Q3 | 2.41 Billion JPY | -3.44% |
| 2016 Q2 | 2.5 Billion JPY | 0.0% |
| 2016 Q1 | 2.5 Billion JPY | 0.0% |
| 2015 FY | - JPY | 0.0% |
| 2015 Q3 | - JPY | 0.0% |
| 2015 Q2 | - JPY | 0.0% |
| 2015 Q4 | - JPY | 0.0% |
| 2014 FY | - JPY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | - USD | -Infinity% |
| Nanobac Pharmaceuticals, Incorporated | - USD | -Infinity% |
| SQZ Biotechnologies Company | 20.9 Million USD | -2052.183% |
| Evofem Biosciences, Inc. | 8000.00 USD | -5624900.0% |
| Santhera Pharmaceuticals Holding AG | 1.75 Million USD | -25534.029% |
| Mesoblast Limited | 100.29 Million USD | -348.677% |
| Propanc Biopharma, Inc. | 58.64 Thousand USD | -767268.098% |
| Genus plc | 228.2 Million USD | -97.195% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| CNBX Pharmaceuticals Inc. | - USD | -Infinity% |
| Marizyme, Inc. | 667.12 Thousand USD | -67353.221% |
| ContraFect Corporation | 2.21 Million USD | -20261.991% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| PsyBio Therapeutics Corp. | - USD | -Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.4 Million USD | -31975.636% |
| Intellipharmaceutics International Inc. | - USD | -Infinity% |
| AXIM Biotechnologies, Inc. | 5.42 Million USD | -8192.669% |
| MultiCell Technologies, Inc. | 36.43 USD | -1235245576.64% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 55.61 Million USD | -709.178% |
| EV Biologics, Inc. | - USD | -Infinity% |
| Q BioMed Inc. | - USD | -Infinity% |
| Emmaus Life Sciences, Inc. | 2.22 Million USD | -20115.633% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | -36534.182% |
| Biomind Labs Inc. | - USD | -Infinity% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 166.1 Million USD | -170.913% |
| Oncotelic Therapeutics, Inc. | 1.89 Million USD | -23603.323% |
| Skye Bioscience, Inc. | 171.23 Thousand USD | -262704.415% |
| Therapeutic Solutions International, Inc. | 5512.00 USD | -8163905.806% |
| THC Farmaceuticals, Inc. | - USD | -Infinity% |
| Arch Therapeutics, Inc. | - USD | -Infinity% |
| IMV Inc. | 27.39 Million USD | -1542.421% |
| Acro Biomedical Co., Ltd. | - USD | -Infinity% |
| Curative Biotechnology, Inc. | - USD | -Infinity% |
| GB Sciences, Inc. | 322 Thousand USD | -139651.553% |
| Alpha Cognition Inc. | - USD | -Infinity% |
| HST Global, Inc. | - USD | -Infinity% |
| CSL Limited | 11.23 Billion USD | 95.996% |
| Halberd Corporation | 150 Thousand USD | -299900.0% |
| Enzolytics Inc. | - USD | -Infinity% |
| Resverlogix Corp. | - USD | -Infinity% |
| Affymax, Inc. | - USD | -Infinity% |
| SYBLEU INC | 300 Thousand USD | -149900.0% |
| Nuo Therapeutics, Inc. | 164.2 Thousand USD | -273947.684% |
| argenx SE | 15.35 Million USD | -2830.832% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 20.31 Million USD | -2115.439% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | 4456.00 USD | -10098643.268% |
| Genscript Biotech Corporation | 287.12 Million USD | -56.724% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 126.3 Thousand USD | -356188.895% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -196157.158% |
| American Oriental Bioengineering, Inc. | 554.59 Thousand USD | -81041.023% |
| Provectus Biopharmaceuticals, Inc. | 25.29 Thousand USD | -1778626.432% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 8.26 Million USD | -5345.305% |
| Cotinga Pharmaceuticals Inc. | - USD | -Infinity% |
| BioStem Technologies, Inc. | 265.63 Thousand USD | -169305.387% |
| ONE Bio Corp. | 592.19 Thousand USD | -75888.099% |
| Reve Technologies, Inc. | 1064.00 USD | -42293133.083% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Agentix Corp. | - USD | -Infinity% |
| LadRx Corporation | - USD | -Infinity% |
| Cell Source, Inc. | - USD | -Infinity% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Regen BioPharma, Inc. | 149.61 Thousand USD | -300673.992% |
| Regen BioPharma, Inc. | 149.61 Thousand USD | -300673.992% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | - USD | -Infinity% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Kadimastem Ltd | 229.69 Thousand USD | -195815.382% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| CytoDyn Inc. | 141 Thousand USD | -319048.936% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | 80 Thousand USD | -562400.0% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | -5654.505% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | - USD | -Infinity% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 369.04 Thousand USD | -121835.028% |
| International Stem Cell Corporation | 445 Thousand USD | -101023.596% |
| Bioxytran, Inc. | - USD | -Infinity% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.15 Million USD | -5421.472% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | 457 Thousand USD | -98368.271% |
| Neutra Corp. | - USD | -Infinity% |
| Windtree Therapeutics, Inc. | 1.16 Million USD | -38659.69% |
| PureTech Health plc | 18.25 Million USD | -2365.753% |
| Coeptis Therapeutics, Inc. | 150 Thousand USD | -299900.0% |
| IXICO plc | 275 Thousand USD | -163536.364% |
| IntelGenx Technologies Corp. | 11.83 Million USD | -3700.997% |
| Gelesis Holdings, Inc. | 26.3 Million USD | -1610.441% |
| CSL Limited | 11.23 Billion USD | 95.996% |
| Cellectis S.A. | 36.21 Million USD | -1142.711% |